Nathen Fuentes
Chief Financial Officer, Telomir Pharmaceuticals, Inc.
Companies
- Lunai Bioworks Inc.Chief financial officer Jan 13, 2025 to Feb 25, 20251
- Telomir Pharmaceuticals, Inc.Chief financial officer Feb 8, 2024 to Feb 8, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Telomir Pharmaceuticals, Inc. TELO101,134 shares3$105.2K at $1.04Feb 8, 2024
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3